| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
J Thorac Cardiovasc Surg 1995;110:998-1004
© 1995 Mosby, Inc.
SURGERY FOR ACQUIRED HEART DISEASE |
Créteil, France
Received for publication Aug. 12, 1994. Accepted for publication Dec. 23, 1994. Address for reprints: D. Loisance, MD, Centre de Recherches Chirurgicales Henri Mondor, Faculté de Médecine, 8 rue du Général Sarrail, 94000 Créteil, France.
Abstract
Human saphenous veins were cryopreserved in 4% human albumin and 10% dimethyl sulfoxide.The effect of cryopreservation on endothelial cells was studied in terms of the anticoagulant activity of thrombomodulin and in terms of cell proliferation. After storage for 2 weeks at -150°C, 0.45 ± 0.07 x 10 5endothelialcells/cm2 were detected in cryopreserved veins and 1.03& plusmn; 0.04 x 105 endothelial cells/cm2 in freshveins ( p <0.01). The thrombin-catalyzed activation of protein C decreased after cryopreservation, indicating altered thrombomodulin activity in the endothelial cells. On a cell number basis, the release of soluble thrombomodulin was three times higher from the cryopreserved endothelium than from the fresh endothelium (p < 0.05). The amount of spontaneous release of von Willebrand factor from the endothelial surface was not significantly different between fresh and cryopreserved veins. Endothelial cells were cultured from fresh veins and from their cryopreserved counterparts. On plating of endothelial cells in primary culture, the number of adhered cells was 0.9 ± 0.09 x 103 cells/cm2 from fresh veins and 0.25 ± 0.03 x 103 cells/cm2 from cryopreserved veins ( p <0.01). The positive immunohistochemical stain for von Willebrand factor indicated that the endothelial cell character was maintained after cryopreservation. The endothelial desquamation with loss of anticoagulant function and the slow proliferation of surviving cells in vitro suggest an impaired endothelial healing in vivo. The loss of anticoagulant activity complicates the problems of the exposure of thrombogenic subendothelial matrix to blood in implanted cryopreserved veins. (J THORAC CARDIOVASC SURG1995;110:998-1004)
This article has been cited by other articles:
|
|
 |
|
  P. Lamm, G. Juchem, S. Milz, M. Schuffenhauer, and B. Reichart Autologous Endothelialized Vein Allograft: A Solution in the Search for Small-Caliber Grafts in Coronary Artery Bypass Graft Operations Circulation, September 18, 2001; 104 (2009): I-108 - I-114. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Aoki, Y. Yamato, M. Tsuchida, T. Souma, K. Yoshiya, T. Watanabe, and J.-i. Hayashi Successful tracheal transplantation using cryopreserved allografts in a rat model Eur. J. Cardiothorac. Surg., August 1, 1999; 16(2): 169 - 173. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Ricotta and L. M. Harris Current Status Of Cryopreserved Saphenous Vein Homografts Perspectives in Vascular Surgery and Endovascular Therapy, January 1, 1999; 12(1): 123 - 132. [Abstract] [PDF]
|
|
|
|
 |
|
 L. Lecerf, M. Moczar, and D. Loisance CELLULAR DEOXYRIBONUCLEIC ACID FRAGMENTATION DURING OPERATIVE COURSE IN HUMAN SAPHENOUS VEIN GRAFTS J. Thorac. Cardiovasc. Surg., December 1, 1997; 114(6): 1117 - 1118. [Full Text]
|
|
|
|
 |
|
 T. V. Bilfinger, A. R. Hartman, Y. Liu, H. I. Magazine, and G. B. Stefano Cryopreserved Veins in Myocardial Revascularization: Possible Mechanism for Their Increased Failure Ann. Thorac. Surg., April 1, 1997; 63(4): 1063 - 1069. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |
